Diabetes, bone and glucose-lowering agents: clinical outcomes.
about
Diabetes, bone and glucose-lowering agents: basic biology.Review article: effects of type 2 diabetes therapies on bone metabolism.Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice.The obesity puzzle: focus on bone turnover after bariatric surgery.Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study.
P2860
Diabetes, bone and glucose-lowering agents: clinical outcomes.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@ast
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@en
type
label
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@ast
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@en
prefLabel
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@ast
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@en
P2860
P1433
P1476
Diabetes, bone and glucose-lowering agents: clinical outcomes.
@en
P2093
Ann V Schwartz
P2860
P2888
P304
P356
10.1007/S00125-017-4283-6
P577
2017-04-27T00:00:00Z
P6179
1085083604